C
Takeda Pharmaceutical Company Limited TAK
$14.75 -$0.44-2.90%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 7.50B 7.91B 7.75B 7.08B 7.53B
Total Other Revenue -- -- -- -- --
Total Revenue 7.50B 7.91B 7.75B 7.08B 7.53B
Cost of Revenue 2.73B 2.65B 2.48B 2.61B 2.57B
Gross Profit 4.77B 5.26B 5.27B 4.47B 4.96B
SG&A Expenses 1.77B 1.80B 1.73B 1.92B 1.81B
Depreciation & Amortization 879.81M 946.30M 877.86M 901.56M 906.40M
Other Operating Expenses 958.94M -298.11M 342.49M -9.65M 494.91M
Total Operating Expenses 7.46B 6.29B 6.52B 6.73B 7.05B
Operating Income 39.68M 1.63B 1.23B 346.00M 474.01M
Income Before Tax 173.16M 803.13M 876.40M -320.14M 415.02M
Income Tax Expenses 16.87M 183.44M 264.99M -299.97M -301.46M
Earnings from Continuing Operations 156.29M 619.69M 611.41M -20.17M 716.48M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -301.60K -410.40K -327.20K -161.70K -237.10K
Net Income 155.99M 619.28M 611.08M -20.33M 716.24M
EBIT 39.68M 1.63B 1.23B 346.00M 474.01M
EBITDA 1.27B 2.92B 2.47B 1.04B 1.74B
EPS Basic 0.10 0.39 0.39 -0.01 0.46
Normalized Basic EPS -0.09 0.52 0.42 0.07 0.07
EPS Diluted 0.10 0.38 0.38 -0.01 0.46
Normalized Diluted EPS -0.09 0.51 0.41 0.07 0.07
Average Basic Shares Outstanding 1.59B 1.58B 1.57B 1.57B 1.57B
Average Diluted Shares Outstanding 1.59B 1.61B 1.59B 1.57B 1.57B
Dividend Per Share 0.00 0.66 -- 0.63 0.00
Payout Ratio 611.42% 9.99% 145.00% -302.39% 130.77%
Weiss Ratings